| ■ 영문 제목 : Global Lenalidomide API Market Growth 2021-2026 | |
 | ■ 상품코드 : LPI-2201K00768 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 90 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 화학, 재료 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦4,941,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,411,500 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦9,882,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 레날리도마이드 API의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (순도 ≧ 98%, 순도 < 98%)와 용도별 시장규모 (레날리도마이드 캡슐, 기타) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 레날리도마이드 API 시장 점유율 - 지역별 레날리도마이드 API 시장규모 - 주요지역의 종류별 시장규모 (순도 ≧ 98%, 순도 < 98%) - 주요지역의 용도별 시장규모 (레날리도마이드 캡슐, 기타) - 미주의 레날리도마이드 API 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 레날리도마이드 API 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 레날리도마이드 API 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 레날리도마이드 API 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 레날리도마이드 API 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Dr. Reddy’s Laboratories Ltd., Johnson Matthey PLC, Changzhou Pharmaceutical Factory, Shilpa Medicare Limited, Biocon Limited, Sun Pharmaceutical Industries Ltd., Shenzhen Haorui, Mac-Chem Products (India) Pvt.Ltd - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Lenalidomide API will have significant change from previous year. By the most conservative estimates of global Lenalidomide API market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Lenalidomide API market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Lenalidomide API market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Purity≥98%
Purity<98%
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Lenalidomide capsules
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Dr. Reddy’s Laboratories Ltd.
Johnson Matthey PLC
Changzhou Pharmaceutical Factory
Shilpa Medicare Limited
Biocon Limited
Sun Pharmaceutical Industries Ltd.
Shenzhen Haorui
Mac-Chem Products (India) Pvt.Ltd
1 Scope of the Report 2 Executive Summary Table 1. Lenalidomide API Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Purity≥98% Table 3. Major Players of Purity<98% Table 4. Global Lenalidomide API Sales by Type (2016-2021) & (Ton) Table 5. Global Lenalidomide API Sales Market Share by Type (2016-2021) Table 6. Global Lenalidomide API Revenue by Type (2016-2021) & ($ million) Table 7. Global Lenalidomide API Revenue Market Share by Type (2016-2021) Table 8. Global Lenalidomide API Sale Price by Type (2016-2021) Table 9. Global Lenalidomide API Sales by Application (2016-2021) & (Ton) Table 10. Global Lenalidomide API Sales Market Share by Application (2016-2021) Table 11. Global Lenalidomide API Value by Application (2016-2021) Table 12. Global Lenalidomide API Revenue Market Share by Application (2016-2021) Table 13. Global Lenalidomide API Sale Price by Application (2016-2021) Table 14. Global Lenalidomide API Sales by Company (2019-2021) & (Ton) Table 15. Global Lenalidomide API Sales Market Share by Company (2019-2021) Table 16. Global Lenalidomide API Revenue by Company (2019-2021) ($ Millions) Table 17. Global Lenalidomide API Revenue Market Share by Company (2019-2021) Table 18. Global Lenalidomide API Sale Price by Company (2019-2021) Table 19. Key Manufacturers Lenalidomide API Producing Area Distribution and Sales Area Table 20. Players Lenalidomide API Products Offered Table 21. Lenalidomide API Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 22. New Products and Potential Entrants Table 23. Mergers & Acquisitions, Expansion Table 24. Global Lenalidomide API Sales by Region (2016-2021) (Ton) Table 25. Global Lenalidomide API Sales Market Share by Region (2016-2021) Table 26. Global Lenalidomide API Revenue by Region (2016-2021) & ($ Millions) Table 27. Global Lenalidomide API Revenue Market Share by Region (2016-2021) Table 28. Americas Lenalidomide API Sales by Country (2016-2021) & (Ton) Table 29. Americas Lenalidomide API Sales Market Share by Country (2016-2021) Table 30. Americas Lenalidomide API Revenue by Country (2016-2021) & ($ Millions) Table 31. Americas Lenalidomide API Revenue Market Share by Country (2016-2021) Table 32. Americas Lenalidomide API Sales by Type (2016-2021) & (Ton) Table 33. Americas Lenalidomide API Sales Market Share by Type (2016-2021) Table 34. Americas Lenalidomide API Sales by Application (2016-2021) & (Ton) Table 35. Americas Lenalidomide API Sales Market Share by Application (2016-2021) Table 36. APAC Lenalidomide API Sales by Region (2016-2021) & (Ton) Table 37. APAC Lenalidomide API Sales Market Share by Region (2016-2021) Table 38. APAC Lenalidomide API Revenue by Region (2016-2021) & ($ Millions) Table 39. APAC Lenalidomide API Revenue Market Share by Region (2016-2021) Table 40. APAC Lenalidomide API Sales by Type (2016-2021) & (Ton) Table 41. APAC Lenalidomide API Sales Market Share by Type (2016-2021) Table 42. APAC Lenalidomide API Sales by Application (2016-2021) & (Ton) Table 43. APAC Lenalidomide API Sales Market Share by Application (2016-2021) Table 44. Europe Lenalidomide API Sales by Country (2016-2021) & (Ton) Table 45. Europe Lenalidomide API Sales Market Share by Country (2016-2021) Table 46. Europe Lenalidomide API Revenue by Country (2016-2021) & ($ Millions) Table 47. Europe Lenalidomide API Revenue Market Share by Country (2016-2021) Table 48. Europe Lenalidomide API Sales by Type (2016-2021) & (Ton) Table 49. Europe Lenalidomide API Sales Market Share by Type (2016-2021) Table 50. Europe Lenalidomide API Sales by Application (2016-2021) & (Ton) Table 51. Europe Lenalidomide API Sales Market Share by Application (2016-2021) Table 52. Middle East & Africa Lenalidomide API Sales by Country (2016-2021) & (Ton) Table 53. Middle East & Africa Lenalidomide API Sales Market Share by Country (2016-2021) Table 54. Middle East & Africa Lenalidomide API Revenue by Country (2016-2021) & ($ Millions) Table 55. Middle East & Africa Lenalidomide API Revenue Market Share by Country (2016-2021) Table 56. Middle East & Africa Lenalidomide API Sales by Type (2016-2021) & (Ton) Table 57. Middle East & Africa Lenalidomide API Sales Market Share by Type (2016-2021) Table 58. Middle East & Africa Lenalidomide API Sales by Application (2016-2021) & (Ton) Table 59. Middle East & Africa Lenalidomide API Sales Market Share by Application (2016-2021) Table 60. Key and Potential Regions of Lenalidomide API Table 61. Key Application and Potential Industries of Lenalidomide API Table 62. Key Challenges of Lenalidomide API Table 63. Key Trends of Lenalidomide API Table 64. Lenalidomide API Distributors List Table 65. Lenalidomide API Customer List Table 66. Global Lenalidomide API Sales Forecast by Region (2021-2026) & (Ton) Table 67. Global Lenalidomide API Consumption Market Forecast by Region Table 68. Global Lenalidomide API Revenue Forecast by Region (2021-2026) & ($ millions) Table 69. Global Lenalidomide API Revenue Market Share Forecast by Region (2021-2026) Table 70. Americas Lenalidomide API Sales Forecast by Country (2021-2026) & (Ton) Table 71. Americas Lenalidomide API Revenue Forecast by Country (2021-2026) & ($ millions) Table 72. APAC Lenalidomide API Sales Forecast by Region (2021-2026) & (Ton) Table 73. APAC Lenalidomide API Revenue Forecast by Region (2021-2026) & ($ millions) Table 74. Europe Lenalidomide API Sales Forecast by Country (2021-2026) & (Ton) Table 75. Europe Lenalidomide API Revenue Forecast by Country (2021-2026) & ($ millions) Table 76. Middle East & Africa Lenalidomide API Sales Forecast by Country (2021-2026) & (Ton) Table 77. Middle East & Africa Lenalidomide API Revenue Forecast by Country (2021-2026) & ($ millions) Table 78. Global Lenalidomide API Sales Forecast by Type (2021-2026) & (Ton) Table 79. Global Lenalidomide API Sales Market Share Forecast by Type (2021-2026) Table 80. Global Lenalidomide API Revenue Forecast by Type (2021-2026) & ($ Millions) Table 81. Global Lenalidomide API Revenue Market Share Forecast by Type (2021-2026) Table 82. Global Lenalidomide API Sales Forecast by Application (2021-2026) & (Ton) Table 83. Global Lenalidomide API Sales Market Share Forecast by Application (2021-2026) Table 84. Global Lenalidomide API Revenue Forecast by Application (2021-2026) & ($ Millions) Table 85. Global Lenalidomide API Revenue Market Share Forecast by Application (2021-2026) Table 86. Dr. Reddy’s Laboratories Ltd. Basic Information, Lenalidomide API Manufacturing Base, Sales Area and Its Competitors Table 87. Dr. Reddy’s Laboratories Ltd. Lenalidomide API Product Offered Table 88. Dr. Reddy’s Laboratories Ltd. Lenalidomide API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 89. Dr. Reddy’s Laboratories Ltd. Main Business Table 90. Dr. Reddy’s Laboratories Ltd. Latest Developments Table 91. Johnson Matthey PLC Basic Information, Lenalidomide API Manufacturing Base, Sales Area and Its Competitors Table 92. Johnson Matthey PLC Lenalidomide API Product Offered Table 93. Johnson Matthey PLC Lenalidomide API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 94. Johnson Matthey PLC Main Business Table 95. Johnson Matthey PLC Latest Developments Table 96. Changzhou Pharmaceutical Factory Basic Information, Lenalidomide API Manufacturing Base, Sales Area and Its Competitors Table 97. Changzhou Pharmaceutical Factory Lenalidomide API Product Offered Table 98. Changzhou Pharmaceutical Factory Lenalidomide API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 99. Changzhou Pharmaceutical Factory Main Business Table 100. Changzhou Pharmaceutical Factory Latest Developments Table 101. Shilpa Medicare Limited Basic Information, Lenalidomide API Manufacturing Base, Sales Area and Its Competitors Table 102. Shilpa Medicare Limited Lenalidomide API Product Offered Table 103. Shilpa Medicare Limited Lenalidomide API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 104. Shilpa Medicare Limited Main Business Table 105. Shilpa Medicare Limited Latest Developments Table 106. Biocon Limited Basic Information, Lenalidomide API Manufacturing Base, Sales Area and Its Competitors Table 107. Biocon Limited Lenalidomide API Product Offered Table 108. Biocon Limited Lenalidomide API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 109. Biocon Limited Main Business Table 110. Biocon Limited Latest Developments Table 111. Sun Pharmaceutical Industries Ltd. Basic Information, Lenalidomide API Manufacturing Base, Sales Area and Its Competitors Table 112. Sun Pharmaceutical Industries Ltd. Lenalidomide API Product Offered Table 113. Sun Pharmaceutical Industries Ltd. Lenalidomide API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 114. Sun Pharmaceutical Industries Ltd. Main Business Table 115. Sun Pharmaceutical Industries Ltd. Latest Developments Table 116. Shenzhen Haorui Basic Information, Lenalidomide API Manufacturing Base, Sales Area and Its Competitors Table 117. Shenzhen Haorui Lenalidomide API Product Offered Table 118. Shenzhen Haorui Lenalidomide API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 119. Shenzhen Haorui Main Business Table 120. Shenzhen Haorui Latest Developments Table 121. Mac-Chem Products (India) Pvt.Ltd Basic Information, Lenalidomide API Manufacturing Base, Sales Area and Its Competitors Table 122. Mac-Chem Products (India) Pvt.Ltd Lenalidomide API Product Offered Table 123. Mac-Chem Products (India) Pvt.Ltd Lenalidomide API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 124. Mac-Chem Products (India) Pvt.Ltd Main Business Table 125. Mac-Chem Products (India) Pvt.Ltd Latest Developments List of Figures Figure 1. Picture of Lenalidomide API Figure 2. Lenalidomide API Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Lenalidomide API Sales Growth Rate 2016-2026 (Ton) Figure 7. Global Lenalidomide API Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Lenalidomide API Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Purity≥98% Figure 10. Product Picture of Purity<98% Figure 11. Global Lenalidomide API Sales Market Share by Type in 2020 Figure 12. Global Lenalidomide API Revenue Market Share by Type (2016-2021) Figure 13. Lenalidomide API Consumed in Lenalidomide capsules Figure 14. Global Lenalidomide API Market: Lenalidomide capsules (2016-2021) & (Ton) Figure 15. Lenalidomide API Consumed in Others Figure 16. Global Lenalidomide API Market: Others (2016-2021) & (Ton) Figure 17. Global Lenalidomide API Sales Market Share by Application (2016-2021) Figure 18. Global Lenalidomide API Revenue Market Share by Application in 2020 Figure 19. Lenalidomide API Revenue Market by Company in 2020 ($ Million) Figure 20. Global Lenalidomide API Revenue Market Share by Company in 2020 Figure 21. Global Lenalidomide API Sales Market Share by Regions (2016-2021) Figure 22. Global Lenalidomide API Revenue Market Share by Region in 2020 Figure 23. Americas Lenalidomide API Sales 2016-2021 (Ton) Figure 24. Americas Lenalidomide API Revenue 2016-2021 ($ Millions) Figure 25. APAC Lenalidomide API Sales 2016-2021 (Ton) Figure 26. APAC Lenalidomide API Revenue 2016-2021 ($ Millions) Figure 27. Europe Lenalidomide API Sales 2016-2021 (Ton) Figure 28. Europe Lenalidomide API Revenue 2016-2021 ($ Millions) Figure 29. Middle East & Africa Lenalidomide API Sales 2016-2021 (Ton) Figure 30. Middle East & Africa Lenalidomide API Revenue 2016-2021 ($ Millions) Figure 31. Americas Lenalidomide API Sales Market Share by Country in 2020 Figure 32. Americas Lenalidomide API Revenue Market Share by Country in 2020 Figure 33. Americas Lenalidomide API Sales Market Share by Type in 2020 Figure 34. Americas Lenalidomide API Sales Market Share by Application in 2020 Figure 35. United States Lenalidomide API Revenue Growth 2016-2021 ($ Millions) Figure 36. Canada Lenalidomide API Revenue Growth 2016-2021 ($ Millions) Figure 37. Mexico Lenalidomide API Revenue Growth 2016-2021 ($ Millions) Figure 38. Brazil Lenalidomide API Revenue Growth 2016-2021 ($ Millions) Figure 39. APAC Lenalidomide API Sales Market Share by Region in 2020 Figure 40. APAC Lenalidomide API Revenue Market Share by Regions in 2020 Figure 41. APAC Lenalidomide API Sales Market Share by Type in 2020 Figure 42. APAC Lenalidomide API Sales Market Share by Application in 2020 Figure 43. China Lenalidomide API Revenue Growth 2016-2021 ($ Millions) Figure 44. Japan Lenalidomide API Revenue Growth 2016-2021 ($ Millions) Figure 45. Korea Lenalidomide API Revenue Growth 2016-2021 ($ Millions) Figure 46. Southeast Asia Lenalidomide API Revenue Growth 2016-2021 ($ Millions) Figure 47. India Lenalidomide API Revenue Growth 2016-2021 ($ Millions) Figure 48. Australia Lenalidomide API Revenue Growth 2016-2021 ($ Millions) Figure 49. Europe Lenalidomide API Sales Market Share by Country in 2020 Figure 50. Europe Lenalidomide API Revenue Market Share by Country in 2020 Figure 51. Europe Lenalidomide API Sales Market Share by Type in 2020 Figure 52. Europe Lenalidomide API Sales Market Share by Application in 2020 Figure 53. Germany Lenalidomide API Revenue Growth 2016-2021 ($ Millions) Figure 54. France Lenalidomide API Revenue Growth 2016-2021 ($ Millions) Figure 55. UK Lenalidomide API Revenue Growth 2016-2021 ($ Millions) Figure 56. Italy Lenalidomide API Revenue Growth 2016-2021 ($ Millions) Figure 57. Russia Lenalidomide API Revenue Growth 2016-2021 ($ Millions) Figure 58. Middle East & Africa Lenalidomide API Sales Market Share by Country in 2020 Figure 59. Middle East & Africa Lenalidomide API Revenue Market Share by Country in 2020 Figure 60. Middle East & Africa Lenalidomide API Sales Market Share by Type in 2020 Figure 61. Middle East & Africa Lenalidomide API Sales Market Share by Application in 2020 Figure 62. Egypt Lenalidomide API Revenue Growth 2016-2021 ($ Millions) Figure 63. South Africa Lenalidomide API Revenue Growth 2016-2021 ($ Millions) Figure 64. Israel Lenalidomide API Revenue Growth 2016-2021 ($ Millions) Figure 65. Turkey Lenalidomide API Revenue Growth 2016-2021 ($ Millions) Figure 66. GCC Country Lenalidomide API Revenue Growth 2016-2021 ($ Millions) Figure 67. Channels of Distribution Figure 68. Distributors Profiles |
| ※본 조사보고서 [세계의 레날리도마이드 API 시장예측 2021년-2026년] (코드 : LPI-2201K00768) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 레날리도마이드 API 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |